Literature DB >> 17766015

Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine.

Julie Patterson-Bartlett1, Myron J Levin, Nancy Lang, Florian P Schödel, Rupert Vessey, Adriana Weinberg.   

Abstract

To define the phenotypic characteristics and kinetics of T cell responses to a shingles vaccine in elderly individuals, 20 subjects > or =60 years of age received two doses of vaccine or placebo 6 weeks apart. VZV-specific T cell phenotypes and intracellular cytokines were determined by flow cytometry on blood mononuclear cells obtained pre-vaccination and up to 6 months after the second immunization. Results were compared with responses of five unvaccinated young adults. Pre-vaccination, elderly individuals had significantly lower VZV-specific effectors and cytokine-producing T cells compared with young adults. The vaccine significantly increased VZV-specific Th1, memory, early effector, and cutaneous homing receptor-bearing T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17766015     DOI: 10.1016/j.vaccine.2007.07.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

Review 1.  Vaccination in the elderly: what can be recommended?

Authors:  Pierre-Olivier Lang; Richard Aspinall
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

Review 2.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

Review 3.  Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia.

Authors:  D Gilden
Journal:  J Intern Med       Date:  2011-02-23       Impact factor: 8.989

4.  Immune correlates of herpes zoster in HIV-infected children and youth.

Authors:  Adriana Weinberg; Sharon Huang; Lin-Ye Song; Terry Fenton; Paige Williams; Julie Patterson; Adriana Tovar-Salazar; Myron J Levin
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

5.  Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

Authors:  Adriana Weinberg; Jane H Zhang; Michael N Oxman; Gary R Johnson; Anthony R Hayward; Michael J Caulfield; Michael R Irwin; James Clair; Jeffrey G Smith; Harold Stanley; Rocio D Marchese; Ruth Harbecke; Heather M Williams; Ivan S F Chan; Robert D Arbeit; Anne A Gershon; Florian Schödel; Vicki A Morrison; Carol A Kauffman; Steve E Straus; Kenneth E Schmader; Larry E Davis; Myron J Levin
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

Review 6.  Vaccines for preventing herpes zoster in older adults.

Authors:  Anna M Z Gagliardi; Brenda N G Andriolo; Maria R Torloni; Bernardo G O Soares
Journal:  Cochrane Database Syst Rev       Date:  2016-03-03

Review 7.  Varicella-zoster.

Authors:  Don Gilden; Maria A Nagel; Randall J Cohrs
Journal:  Handb Clin Neurol       Date:  2014

8.  The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging.

Authors:  Milica Vukmanovic-Stejic; Daisy Sandhu; Judith A Seidel; Neil Patel; Toni O Sobande; Elaine Agius; Sarah E Jackson; Judilyn Fuentes-Duculan; Mayte Suárez-Fariñas; Neil A Mabbott; Katie E Lacy; Graham Ogg; Frank O Nestle; James G Krueger; Malcolm H A Rustin; Arne N Akbar
Journal:  J Invest Dermatol       Date:  2015-03-03       Impact factor: 8.551

9.  Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.

Authors:  Kerry J Laing; Ronnie M Russell; Lichun Dong; D Scott Schmid; Michael Stern; Amalia Magaret; Jürgen G Haas; Christine Johnston; Anna Wald; David M Koelle
Journal:  J Infect Dis       Date:  2015-03-17       Impact factor: 5.226

10.  Cytotoxicity of glioblastoma cells mediated ex vivo by varicella-zoster virus-specific T cells.

Authors:  Jennifer Canniff; Andrew M Donson; Nicholas K Foreman; Adriana Weinberg
Journal:  J Neurovirol       Date:  2011-07-27       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.